Long before confusion sets in, your genes and blood may already be signaling trouble. This study of more than a million people reveals the hidden biological warnings that could transform how we predict and prevent delirium.
Study:

Long before confusion sets in, your genes and blood may already be signaling trouble. This study of more than a million people reveals the hidden biological warnings that could transform how we predict and prevent delirium.
Study:

Nvidia has claimed it is “a generation ahead” of rivals in the artificial intelligence (AI) industry amid growing suggestions a rival may emerge to threaten to its market dominance – and multi-trillion dollar valuation.
Shares in the chip giant fell on Tuesday, following a report Meta planned to spend billions on AI chips developed by Google to power its data centres.
In a statement on X, Nvidia, the world’s most valuable company, said it was the only platform which “runs every AI model and does it everywhere computing is done”.
In response, Google said it was committed to “supporting both” its own and Nvidia’s chips.
Nvidia’s chips have become a critical part of powering the data centres behind many of the most popular AI tools, such as ChatGPT.
In October it became the first company ever to be valued at $5tn (£3.8tn).
The American firm has been looking to expand its reach further in recent months, announcing an agreement in October to supply some of its most advanced artificial intelligence (AI) chips to South Korea’s government, as well as Samsung, LG, and Hyundai.
Google rents access to its chips, called tensor processing units (TPUs), through Google Cloud to AI developers.
In other words, they are not sold externally – but kept for the tech giant’s own data centres.
But if recent reports are correct – that the tech company could be in talks to sell its chips to power other data centres – it would represent a significant change.
The news saw Nvidia shares fall nearly 6% on Tuesday, whilst those in Alphabet, Google’s parent company, rose by nearly the same percentage.
In the hours following the drop, the chip giant posted on X to state it still offered “greater performance” and “versatility” than the types of chips Google is producing.
In the past year, both Amazon and Microsoft have announced they also have AI chips in development.
Dame Wendy Hall, Regius Professor of Computer Science at the University of Southampton, told the BBC’s Today programme the news of the potential deal between Google and Meta was “healthy” for the market.
“Investment is pouring into this area,” she said.
“At the moment there is no real return on that investment except for Nvidia”.

In a crowded post-minimalist world, Hania Rani has carved herself out a respectable niche. The Polish pianist and composer’s erudite yet accessible work often defies genres, appealing to classical, jazz and electronic aficionados alike. This…

Pakistan Army chief, Field Marshal Asim Munir, on Wednesday claimed that the “professionalism” displayed by the armed forces during the May conflict with India has enhanced Pakistan’s standing on the global stage. He made the remarks while…

Giovanni Malagò, in his speech during the Ceremony, emphasized the symbolic importance of the event: “By participating in this ceremony, it is…

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Arturia has announced the release of AstroLab 37, a slimmed-down 37-key version of its Analog Lab-powered “avant-garde stage keyboard”.
Released in 2024, AstroLab squeezed hundreds of sounds from Arturia’s Analog Lab software into a 61-key stage…